In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database

• Chengkai Yang ,

  Contributed equally to this work with: Chengkai Yang, Qian Guo, Yang Cheng

  Roles Data curation, Formal analysis, Investigation

  Affiliation Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

  ⨯
• Qian Guo ,

  Contributed equally to this work with: Chengkai Yang, Qian Guo, Yang Cheng

  Roles Data curation, Formal analysis

  Affiliation Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

  ⨯
• Yang Cheng ,

  Contributed equally to this work with: Chengkai Yang, Qian Guo, Yang Cheng

  Roles Data curation, Formal analysis

  Affiliation Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

  ⨯
• Fengjing Liu,

  Roles Resources, Writing – review & editing

  Affiliation Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

  ⨯
• Hui Zhang,

  Roles Resources, Writing – review & editing

  Affiliation Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

  ⨯
• Huaxiang Wang

  Roles Formal analysis, Investigation, Methodology, Writing – review & editing

  * E-mail: whx19930307@163.com

  Affiliation Department of Hepatobiliary and Pancreatic Surgery, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, Hubei province, China

  https://orcid.org/0000-0003-1589-4513

  ⨯